The 25 references in paper A. Ignatova V., A. Mudunov M., M. Narimanov N., А. Игнатова В., А. Мудунов М., М. Нариманов Н. (2015) “ПРОГНОСТИЧЕСКОЕ ЗНАЧЕНИЕ БИОМАРКЕРОВ ПРИ ПЛОСКОКЛЕТОЧНОМ РАКЕ ПОЛОСТИ РТА. ОБЗОР ЛИТЕРАТУРЫ // PROGNOSTIC SIGNIFICANCE OF BIOMARKERS IN ORAL SQUAMOUS CELL CARCINOMA. REVIEW” / spz:neicon:ogsh:y:2014:i:4:p:28-33

1
VEGFR и др. [86]. Терапевтические подходы, такие как использование некоторых молекулярных ингибиторов, направленных против конкретных биомаркеров, наряду с адъювантной лучевой терапией и / или химиотерапией могут иметь большие перспект
(check this in PDF content)
2
III β-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma. Ann Oncol 2009;20(8):141
(check this in PDF content)
3
Bernardo V. et al. Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma. Oral Onc
(check this in PDF content)
4
Fernandez P. et al. Expression of Bcl-2 but not Bax has a prognostic significance in tongue carcinoma. J Oral Pathol Med 2006;35(3):140–5. 32. Kato K., Kawashiri S., Yosh
(check this in PDF content)
5
Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma. Oncology 2005;68:31
(check this in PDF content)
6
Imoto M. Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci 2007;98:629–35. 35. Chari N. S., Pinaire N. L., Thor
(check this in PDF content)
7
Zucoloto S. Prognostic impact of p53 and p63 immunoexpression in oral squamous cell carcinoma. J Oral Pathol Med 2007;36(4):191–7. 38. Oliveira L. R., Ribe
(check this in PDF content)
8
Zucoloto S. Prognostic significance of p53 and p63 immunolocalisation in primary and matched lymph node metastasis in oral squamous cell carcinoma. Acta Histochem 2007;109(5):388–96. 39.
(check this in PDF content)
9
Effect of p63 expression on survival in oral squamous cell carcinoma. Cancer Invest 2007;25:464–9. 42. Nemes J. A., Nemes Z., Marton I.J. p21WAF1 / CIP1 expression is a marker of poor prognostic
(check this in PDF content)
10
Survivin as prognostic factor in squamous cell carcinoma of the oral cavity. Cancer Lett 2005;225:27–33. 46. Jun H. J., Ahn M. J., Kim H
(check this in PDF content)
11
Expression of carbonic anhydrase IX is associated with postoperative recurrence and poor prognostic in surgically treated oral squamous cell carcinoma. Hum Pathol 2008;39(9):1317–22. 52. Jansse
(check this in PDF content)
12
Balm A. J., Begg A. C. Hypoxia in head and neck cancer: how much, how important? Head Neck 2005;27:622–38. 53. Sakata K., Someya M., Nagakura H. et al. Brachytherapy for oral tongue cancer:
(check this in PDF content)
13
Quintero M. Hypoxia-inducible factor 1 alpha in oral cancer. J Oral Pathol Med 2005;34(7):385–9. 55. van de Pol S. M., Doornaert P. A., de Bree R. et al. The significance of
(check this in PDF content)
14
Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognostic of oral squa- mous cell carcinomas in T
(check this in PDF content)
15
Shang Z. J. Expression of EphA2 and VEGF in squamous cell carcinoma of the tongue: correlation with the angiogenesis and clinical outcome. Oral Oncol
(check this in PDF content)
16
Lackmann M. Eph-modulated cell morphology, adhesion and motility in carcinogenesis. IUBMB Life 2005;57(6):421–31. 66. Kyzas P. A., Cunha I. W.,
(check this in PDF content)
17
Ioannidis J. P. Prognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: a met
(check this in PDF content)
18
Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression. J Surg Oncol 2006;93(4):330–7. 72. Kosunen A., Pirinen R.,
(check this in PDF content)
19
Puisieux A., Galmarini C. M. p53 as a target for anti-cancer drug development. Crit Rev Oncol Hematol 2006;58:190–207. 76. Curran D., Giralt J., Harari P. M. et
(check this in PDF content)
20
Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol 2007;25:2152–5. 77. Garcia-Montesinos-Per
(check this in PDF content)
21
Bernal J. F., Saiz-Bustillo R. Epidermoid carcinoma of the lip: an immunohistochemical study. Med Oral Patol Oral Cir Bucal 2005;10(5):454–61. 78. Georgolios A., Batistatou A.,
(check this in PDF content)
22
Charalabopoulos A. et al. The role of CD44 adhesion molecule in oral cavity cancer. Exp Oncol 2006;28(2):94–8. 79. Gonzalez-Moles M. A., Gil-Montoya J. A.,
(check this in PDF content)
23
Ruiz-Avila I. et al. Prognostic significance of p21WAF1 / CIP1, p16INK4a and CD44s in tongue cancer. Oncol Rep 2007;18(2):389–96. 80. Lo Muzio L., Campisi G., Fa
(check this in PDF content)
24
Expression of SIP1 in oral squamous cell carcinomas: implications for E-cadherin expression and tumor progression. Int J Oncol 2005;27:1535–41. 82. Pukkila M., Kosunen A., Ropponen K. et al. High s
(check this in PDF content)
25
Ioannidis J. P. Almost all articles on cancer prognostic markers report statistically significant results. Eur J Cancer 2007;43(17):2559–79. 86. Dorsey K., Agulnik
(check this in PDF content)